235 related articles for article (PubMed ID: 9830263)
1. Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
Syed TA; Ahmadpour OA; Ahmad SA; Shamsi S
J Dermatol; 1998 Oct; 25(10):648-52. PubMed ID: 9830263
[TBL] [Abstract][Full Text] [Related]
2. Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
Friedman-Birnbaum R; Cohen A; Shemer A; Bitterman O; Bergman R; Stettendorf S
Int J Dermatol; 1997 Jan; 36(1):67-9. PubMed ID: 9071624
[TBL] [Abstract][Full Text] [Related]
3. Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream.
Syed TA; Qureshi ZA; Ali SM; Ahmad S; Ahmad SA
Trop Med Int Health; 1999 Apr; 4(4):284-7. PubMed ID: 10357864
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
[TBL] [Abstract][Full Text] [Related]
5. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
6. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.
Scher RK; Breneman D; Rich P; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S77-86. PubMed ID: 9631989
[TBL] [Abstract][Full Text] [Related]
7. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
Gupta AK; Fleckman P; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
Tavakkol A; Fellman S; Kianifard F
Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.
Elewski BE; Scher RK; Aly R; Daniel R; Jones HE; Odom RB; Zaias N; Jacko ML
Cutis; 1997 Apr; 59(4):217-20. PubMed ID: 9104548
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.
Tausch I; Bräutigam M; Weidinger G; Jones TC
Br J Dermatol; 1997 May; 136(5):737-42. PubMed ID: 9205509
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
Gupta AK; Leonardi C; Stoltz RR; Pierce PF; Conetta B;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):437-43. PubMed ID: 15987289
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis.
Faergemann J; Anderson C; Hersle K; Hradil E; Nordin P; Kaaman T; Molin L; Pettersson A
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):750-3. PubMed ID: 7722020
[TBL] [Abstract][Full Text] [Related]
14. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail.
Ling MR; Swinyer LJ; Jarratt MT; Falo L; Monroe EW; Tharp M; Kalivas J; Weinstein GD; Asarch RG; Drake L; Martin AG; Leyden JJ; Cook J; Pariser DM; Pariser R; Thiers BH; Lebwohl MG; Babel D; Stewart DM; Eaglstein WH; Falanga V; Katz HI; Bergfeld WF; Hanifin JM; Young MR
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S95-102. PubMed ID: 9631991
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine in onychomycosis of the toenail: a novel treatment protocol.
Watson A; Marley J; Ellis D; Williams T
J Am Acad Dermatol; 1995 Nov; 33(5 Pt 1):775-9. PubMed ID: 7593777
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of terbinafine for toenail onychomycosis. A multicenter trial of various treatment durations.
Pollak R; Billstein SA
J Am Podiatr Med Assoc; 2001 Mar; 91(3):127-31. PubMed ID: 11266494
[TBL] [Abstract][Full Text] [Related]
17. Onychomycosis in children: treatment with bifonazole-urea.
Bonifaz A; Ibarra G
Pediatr Dermatol; 2000; 17(4):310-4. PubMed ID: 10990584
[TBL] [Abstract][Full Text] [Related]
18. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
De Backer M; De Vroey C; Lesaffre E; Scheys I; De Keyser P
J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939
[TBL] [Abstract][Full Text] [Related]
19. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
[TBL] [Abstract][Full Text] [Related]
20. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail.
Drake L; Babel D; Stewart DM; Rich P; Ling MR; Breneman D; Scher RK; Martin AG; Pariser DM; Pariser RJ; Ellis CN; Kang S; Katz HI; McDonald CJ; Muglia J; Savin RC; Webster G; Elewski BE; Leyden JJ; Bucko AD; Tschen EH; Hanifin JM; Morman MR; Shupack JL; Greer DL
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S87-94. PubMed ID: 9631990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
